ADD WebEx/TEAMS MEETING LINK

OBJECTIVES: Upon completion of this activity, the participant should be able to:
1. Review the growing burden of cardiometabolic diseases and underutilization of evidence-based therapies for the same.
2. Identify the challenges with implementation of evidence-based therapies in clinical practice for management of cardiometabolic diseases.
3. Describe the role of risk-based approach to prevention in contemporary clinical practice.

FACULTY DISCLOSURE: Ambarish Pandey, MD, PhD is a Consultant/Advisor for Tricog Health Inc, Lilly USA, Rivus, Roche Diagnostics, Axon therapies, Medtronic, Edward Lifesciences, Science37, Novo Nordisk, Bayer, Merck, Sarfez Pharmaceuticals, Palomarin Inc., has Research Grants to Institutions at Gilead Sciences, Applied Therapeutics, and Myovista, and was a Consultant/Advisor at Cytokinetics and Emmi Solutions.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Javed Butler, MD is a consultant for Abbott, American Regent, Amgen, Applied Therapeutic, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardiac Dimension, Cardior, CVRx, Cytokinetics, Daxor, Edwards, Element Science, Innolife, Impulse Dynamics, Imbria, Inventiva, Lexicon, Lilly, LivaNova, Janssen, Medtronics, Merck, Occlutech, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Roche, Secretome, Sequana, SQ Innovation, Tenex, Vifor.

CONTENT REVIEWER DISCLOSURE: Alaina Tellson PhD, RN, NPD-BC, NE-BC; and Crystal Brooks, LCSW, ACM-SW, CTP  have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES: Baylor Scott & White Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

SOCIAL WORKERS: This program has been screened and determined to be related to the practice of social work to the best of our ability. The Behavioral Health Executive Council will make the final determination as to whether the activity claimed by the licensee is directly related to the practice of social work. BSWH SW CE Approval # 686516

Session date: 
06/19/2024 - 12:00pm to 1:00pm CDT
Location: 
Virtual WebEx
United States
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 ANCC
    Baylor Scott & White Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • 1.00 Attendance
  • 1.00 Texas State Board of Social Work Examiners
    This offering is approved for 1.00 CEU. Scott and White provider number CS4934 has been awarded Provider Status by the Texas State Board of Social Work Examiners. This approval meets criteria for mandatory continuing education requirements for relicensure as established by the Texas State Board of Social Work Examiners.

Please login or register for this course.